Dicot Pharma AB (FRA:KN0) Net Margin %: 0.00% (As of Mar. 2026)


FRA:KN0 Dicot Pharma AB FRA:KN0
23 GF Score
Price €0.01
! 2 Warning Signs
View Full Analysis

What is Dicot Pharma AB Net Margin %?

Dicot Pharma AB FRA:KN0 -4.96% 23 Net Margin % is 0.00% as of Mar. 2026. GuruFocus rates FRA:KN0 with a GF Score™ of 23/100. The stock has 2 warning signs investors should review. Among 956 Drug Manufacturers companies, Dicot Pharma AB ranks worse than 104602.41% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Dicot Pharma AB's Net Income for the three months ended in Mar. 2026 was €-1.37 Mil. Dicot Pharma AB's Revenue for the three months ended in Mar. 2026 was €0.00 Mil. Therefore, Dicot Pharma AB's net margin for the quarter that ended in Mar. 2026 was 0.00%.

The historical rank and industry rank for Dicot Pharma AB's Net Margin % or its related term are showing as below:


FRA:KN0's Net Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 5.56
* Ranked among companies with meaningful Net Margin % only.

Dicot Pharma AB  (FRA:KN0) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Dicot Pharma AB Net Margin % Related Terms

Dicot Pharma AB Net Margin % Historical Data

* Premium members only.

The historical data trend for Dicot Pharma AB's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dicot Pharma AB Net Margin % Chart

Dicot Pharma AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Net Margin %
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

Dicot Pharma AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

FRA:KN0 vs ZTS: Net Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Dicot Pharma AB's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dicot Pharma AB Net Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dicot Pharma AB's Net Margin % distribution charts can be found below:

* The bar in red indicates where Dicot Pharma AB's Net Margin % falls into.


FRA:KN0
23GF Score
Dicot Pharma AB FRA:KN0
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dicot Pharma AB Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Dicot Pharma AB's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-7.373/0
= %

Dicot Pharma AB's Net Margin for the quarter that ended in Mar. 2026 is calculated as

Net Margin=Net Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-1.374/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
Dicot Pharma AB (FRA:KN0) has a Net Margin % of 0.00% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Dicot Pharma AB and its competitors. According to the industry distribution chart, Dicot Pharma AB ranks #999999 out of 956 companies in the Drug Manufacturers industry.
Is Dicot Pharma AB's Net Margin % too high?
Dicot Pharma AB's current Net Margin % is 0.00%. Based on the distribution chart, Dicot Pharma AB ranks #999999 out of 956 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Dicot Pharma AB has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Dicot Pharma AB's Net Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Dicot Pharma AB ranks #999999 out of 956 companies for Net Margin %. This places Dicot Pharma AB in the lower half of its industry. The industry median Net Margin % is 5.56. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.56, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Dicot Pharma AB and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dicot Pharma AB's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dicot Pharma AB stock overvalued right now?
Dicot Pharma AB (FRA:KN0) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. Dicot Pharma AB's overall GF Score™ is 23/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Dicot Pharma AB (FRA:KN0), the current Net Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Dicot Pharma AB Business Description

Other Exchanges DICOT:SwedenKN0:Germany
Address S:t Olofsgatan 11A, Uppsala, SWE, SE 753 21
Dicot Pharma AB is developing a modern potency medicine that will treat erectile dysfunction and premature ejaculation than existing preparations. The business model involves evaluating industrial and financial partnerships during clinical development to bring LIB-01 to commercialization on the world market. The company's drug candidate LIB-01 has a longer duration of action and fewer side effects, and is also used in the treatment of erectile dysfunction and premature ejaculation.
23GF Score

Get the complete analysis for FRA:KN0

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.01
Price